Clinical trials and observational studies have shown that antihypertensive medication is safe and effective at lowering blood pressure (BP).¹ The BP lowering effect of antihypertensive medication reduces the risk for cardiovascular disease (CVD) events and all-cause mortality.² Despite the benefits of antihypertensive medication, over 50% of US adults taking antihypertensive medication have uncontrolled BP.³ One explanation for the low prevalence of BP control among adults taking antihypertensive medication is nonadherence.^4,5 A number of potential reasons for antihypertensive medication nonadherence have been described in prior studies.^6,7 One frequently cited reason for nonadherence is an inability to pay for antihypertensive medication (i.e., cost-related medication nonadherence).^6,7

中文翻译：

---

与成本相关的抗高血压药物不依从性：COVID-19 及以后的行动。

临床试验和观察性研究表明，抗高血压药物在降低血压 (BP) 方面是安全有效的。¹抗高血压药物的降压作用降低了心血管疾病 (CVD) 事件和全因死亡率的风险。²尽管抗高血压药物有好处，但超过 50% 服用抗高血压药物的美国成年人的血压不受控制。³服用抗高血压药物的成年人血压控制率低的一种解释是不依从。^4、5在先前的研究中已经描述了抗高血压药物不依从性的许多潜在原因。^6、7一个经常被引用的不依从性原因是无法支付抗高血压药物的费用（即与成本相关的药物不依从性）。^6、7